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Abstract
Background: Cardiovascular disease is the leading cause of death in women and men. Psyllium, a
soluble fiber has been known to reduce serum lipids. In this pilot study, we evaluated whether
menopausal status would affect the serum lipid responses to psyllium fiber in women.
Methods: Eleven post-menopausal and eight pre-menopausal women with serum total cholesterol
>200 mg/dL were included in the study. Subjects consumed their habitual diet and 15 g psyllium/d
for 6 weeks. Psyllium was incorporated into cookies. Each cookie contained ≈5 g of psyllium fiber.
Subjects ate one cookie in each meal.
Results: With psyllium fiber, total cholesterol concentration was significantly lower (≈5.2%, P <
0.05) in post-menopausal women but not in pre-menopausal women (≈1.3%). Also, there was a
significant decrease in HDL-cholesterol in post-menopausal women (≈10.2%, P < 0.05). There were
no significant changes observed in concentrations of LDL-cholesterol, triglycerides, apolipoprotein
A1, and apolipoprotein B in both pre- and post-menopausal women with psyllium.
Conclusion: In this pilot study, post- and pre-menopausal, hypercholesterolemic women
responded differently to psyllium fiber supplementation. Post-menopausal women would benefit
from addition of psyllium to their diets in reducing the risk for heart diseases. The results of this
study should be used with caution because the study was based on a small sample size.
Introduction
Cardiovascular disease (CVD) is the leading cause of
death among women and men. About 13 million Ameri-
cans have CVD and approximately 450,000 people die
each year in the US from CVD [1]. Risk factors for CVD in
women include post-menopausal status, age, hyperten-
sion, smoking, and diabetes [2]. The onset of menopause
coincides with elevated serum lipids such as total choles-
terol, LDL-cholesterol, and triglycerides and decreased
HDL-cholesterol [3]. Elevated serum lipids in post-meno-
pausal women are partly due to the loss of estrogen [4].
Hormone therapy showed a reduction in LDL-cholesterol
and an increase in HDL-cholesterol [5]. It also frequently
increased triglycerides by increasing the production of
triglyceride-rich VLDLs [6]. Additionally, hormone ther-
apy increased the risk for stroke, breast cancer, and chole-
cystitis [7]. Hormone replacement therapy is not for all
post-menopausal women [8].
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less expensive and cost effective for primary intervention
of heart diseases [9]. Consumption of foods containing
dietary fiber, may improve the long-term maintenance of
low atherogenic LDL-cholesterol [10]. Psyllium (Plantago
ovata) seed husk fiber, a widely used soluble fiber, has
been known to reduce serum total cholesterol and LDL-
cholesterol [11-13]. Additionally, psyllium fiber supple-
mentation with 10 mg of simvastatin (hypocholestero-
lemic drug) was as effective as 20 mg of simvastatin alone
[14]. This suggests that psyllium fiber is an effective adju-
vant hypocholesterolemic agent.
There is a paucity of data on how fiber therapy modulates
the risk for CVD in women. Previous studies conducted in
women indicated that dietary therapy for lowering serum
lipids differs according to menopausal status [15]. In men
compared to post-menopausal women, a greater decrease
was observed in total cholesterol after 4 months of high
fiber diet [16] suggesting that gender differences exist in
hypocholesterolemic effect of dietary fiber. Limited stud-
ies were conducted comparing lipid responses to psyllium
fiber intervention in pre- and post-menopausal women.
Therefore, we tested the hypothesis of whether serum
lipid responses to psyllium fiber intake in post-menopau-




A total of 25 hypercholesterolemic women (13 pre-meno-
pausal and 12 post-menopausal) were recruited for the
study. Hypercholesterolemia was defined as having serum
cholesterol >200 mg/dL. Subjects were recruited from San
Francisco and surrounding communities through posting
of flyers. Participants lived in their homes during the
study. The exclusion criteria were smoking, diabetes, preg-
nancy, breast feeding, allergic to psyllium fiber, and blood
cholesterol ≤200 mg/dL. Individuals with thyroid and gas-
trointestinal diseases, CVD, chronic alcohol and drug
abuse, individuals who were taking lipid-lowering and/or
anti-hypertensive medications, and individuals who were
on estrogen replacement therapy were excluded from the
study. Also, strict vegetarians (vegans) were excluded from
the study because their habitual fiber intake is generally
higher than non-vegetarians. Post-menopausal status was
defined as women who were into menopause at least one
year from their last menstruation at the beginning of the
study. Subjects were asked to continue their habitual diet
and to maintain their pre-study physical activities and
body weights. Study protocol and informed consent were
approved by the Human Subjects Protection Committee
at San Francisco State University.
Administration of psyllium fiber
Subjects were asked to consume psyllium fiber enriched
cookies for 6 weeks. We incorporated 15 g of psyllium
fiber into cookies (≈5 g/cookie). Subjects consumed 3
cookies/d (one in each meal). Psyllium fiber enriched
cookies were made in the departmental food laboratory,
according to the formulation given in Table 1. Previous
studies documented that 4–6 week feeding period was
adequate to observe changes in serum lipids with psyl-
lium fiber intake [17,18]. The reason that psyllium fiber
was incorporated into cookies rather than administering
as supplements because fiber has shown to produce max-
imum cholesterol-lowering effect when it is taken mixed
with foods [19]. Numerous products (muffins and pow-
dered drink mixes) incorporating psyllium were tested for
palatability and cookies yielded the most appetizing prod-
uct. Cookies were individually supplied to subject's home
in a fresh or frozen form on a weekly basis. The rationale
for the amount of fiber used (15 g/d) was based on the
recommendation of 25–35 g/d of fiber intake for adults
[20]. Since Americans consume about 15 g/d of fiber [11],
by adding 15 g/d subjects would meet the recommenda-
tions for fiber. During the study, subjects were asked to
refrain from consuming fiber supplements. If a subject
was a social drinker that subject was asked to maintain her
usual alcohol intake level.
Serum lipid analysis
Twelve-hour overnight fasting blood samples were
obtained from venipuncture in the arm at the beginning
and at the end of the 6-week period by a certified phlebot-
omist. Blood samples were centrifuged and serum was
separated before lipid analysis. Serum samples were ana-
lyzed for total cholesterol, LDL-cholesterol, HDL-choles-
terol, triglycerides, apolipoprotein A-1, and
apolipoprotein B using an automatic analyzer (Quest
Diagnostic Laboratories, Dublin, CA).
Table 1: Composition of psyllium fiber-enriched cookies*
Ingredients Amount#
Psyllium fiber, g 250
All purpose flour, g 252
Sugar, g 294
Brown sugar, g 316.5
Shortening, g 484
Eggs, g 200
Baking soda, g 4.68
Vanilla extract, mg 3.5
* = Procedures: Mixed dry and wet ingredients well. Weighed the 
dough and divided by 50. Baked at 330°F for 11–14 minutes until 
cookies became light golden brown. # = Made 50 cookies. Each 
cookie contained approximately 5 g of psyllium fiber.Page 2 of 5
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Data were presented as mean ± standard deviation. Paired
t-test was used to determine the significant difference
between the baseline and the post-fiber treatment values
in pre- and post-menopausal women (Microsoft Excel for
Windows, 1999). Statistical significance was set at P <
0.05.
Results
Of 25 subjects, 19 (8 pre- and 11 post-menopausal)
women completed the study. Reasons for discontinuation
of participation included gastrointestinal discomfort,
increased frequency of bowel movements, softer stools,
and personal travel and time conflicts. Subjects' character-
istics were summarized in Table 2. As expected, the post-
menopausal women were significantly older compared to
pre-menopausal women (p < 0.05). Body mass index
(BMI) at baseline between pre- and post-menopausal
women was not significantly different. BMI for all subjects
were within the desirable low health risk range. There
were no significant differences in body weight between
baseline to post-study measurements in both pre- and
post-menopausal women (data are not shown).
The baseline and post-study serum lipid concentrations
for pre- and post-menopausal women are presented in
Table 3. Mean serum total cholesterol concentration with
psyllium fiber intake was significantly lower compared to
baseline values in post-menopausal women (218.7 mg/
dL vs. 230.8 mg/dL; p < 0.05) but not in pre-menopausal
women (240.5 mg/dL vs. 243.6 mg/dL). The decrease in
post-menopausal women with respect to total serum cho-
lesterol was ≈5.2%.
Mean HDL cholesterol was significantly lower in post-
menopausal women with fiber intake (65 mg/dL to 58.4
mg/dL) (p < 0.05). In contrast, no change was observed in
HDL-cholesterol concentrations in pre-menopausal
women with psyllium. Changes in LDL-cholesterol in pre-
and post-menopausal women from baseline to post-study
were not significant although there was a slight decline in
values with psyllium fiber intake. The decline was ≈4.6%
in post-menopausal women and was ≈3.2% in pre-meno-
pausal women.
There was a ≈7.6% and ≈18.6% increase in serum triglyc-
erides in pre- and post-menopausal women, respectively,
with psyllium fiber supplementation. However, these
changes were not statistically significant. Similarly, there
were no significant changes in response to psyllium fiber
intake in serum apolipoprotein A-1 and apolipoprotein B
concentrations in both pre- and post-menopausal
women.
Discussion
We investigated the effect of psyllium fiber intake at 15 g/
d dosage level for 6 weeks on serum lipids in free-living,
pre- and post-menopausal, hypercholesterolemic women.
Psyllium fiber significantly lowered serum total choles-
terol in post-menopausal women. Decreased total serum
cholesterol was primarily due to changes in the HDL-cho-
lesterol. Although LDL-cholesterol was lower (≈4.6%)
with fiber intake, the decrease was not statistically signifi-
cant when compared to baseline values in post-menopau-
sal women. Concentrations of serum triglycerides,
apolipoprotein A-1, and apolipoprotein B were not
affected by psyllium fiber intake in post-menopausal
women. Also, psyllium fiber intake had no effect on
serum total cholesterol, LDL-cholesterol, HDL-choles-
terol, triglycerides, apolipoprotein A-1, and apolipopro-
tein B in pre-menopausal, hypercholesterolemic women.
Previously, we documented cholesterol-lowering effect of
psyllium in normocholesterolemic humans [18]. Other
studies have shown that consumption of psyllium fiber
reduced serum total cholesterol and LDL-cholesterol in
hypercholesterolemic subjects [12,13]. Several other
investigators reported a 3–17% reduction of serum total
cholesterol and a 4–20% reduction of LDL-cholesterol
with psyllium fiber [12,19,21,22]. In a meta-analysis,
Anderson et al. (2000b) reported that consumption of
10.2 g psyllium/d lowered total cholesterol by 4%.
Whereas, in our study, we achieved a ≈5.2% decrease in
total serum cholesterol concentrations at a dosage level of
Table 2: Characteristics of subjects*
Variable Pre-menopausal women Post-menopausal women
Race-ethnicity
White/Hispanic/Asian, n 1/1/6 0/0/11
Age, y 34.6 ± 11.5 52.9 ± 2.8#
Weight, kg 63.2 ± 9.3 57.6 ± 5.6@
Height, m 1.6 ± 0.1 1.6 ± 0.04@
BMI, kg/m2 24.2 ± 4.2 22.6 ± 2.2@
* = Mean ± standard deviation. # = Significant difference from pre-menopausal women (p < 0.05).
@ = No significant difference from pre-menopausal women.Page 3 of 5
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ous studies was either in the form of ready-to-eat cereal or
as fiber supplement. In our study, we administered psyl-
lium fiber in cookies. Thus, the method of administration
of psyllium might account for some differences in choles-
terol-lowering property of psyllium fiber in various stud-
ies.
Davidson et al. [10] reported that consumption of psyl-
lium fiber lowered total cholesterol without modifying
HDL-cholesterol concentrations. In contrast, our study
did not reveal that psyllium fiber reduced serum total cho-
lesterol without lowering HDL-cholesterol. The discrep-
ancy in results between this study and other studies may
likely be due to differences in characteristics of subjects.
Also, our subjects consumed self-selected diets during the
study. Thus, the diet intake might have some influence on
the study outcomes.
In this study, we found the hypocholesterolemic effect of
psyllium fiber in post-menopausal women but not in pre-
menopausal women indicating that pre- and post-meno-
pausal women responded differently to psyllium fiber.
Lack of significant hypocholesterolemic effect of psyllium
fiber in pre-menopausal women suggests that the elevated
cholesterol concentrations in those subjects might be due
to genetic causes and thus are unresponsive to dietary
modification. On the other hand, elevated cholesterol in
post-menopausal women is often due to deranged lipid
metabolism (non-genetic causes) arising from loss of
estrogen function and thus is responsive to psyllium fiber
intervention. In post-menopausal women with estab-
lished CVD, higher intake of fiber has been associated
with less progression of coronary atherosclerosis [23].
Also, psyllium fiber significantly reduced post-prandial
concentrations of serum triglycerides, glucose, and insulin
in persons with diabetes [24] suggesting a role for psyl-
lium fiber in the management of diabetes.
Previous studies on the effect of psyllium fiber on triglyc-
erides yielded equivocal results [22,25,26]. Psyllium fiber
intake significantly reduced plasma triglycerides in men,
but in post-menopausal women, it resulted in a signifi-
cant increase with no change in pre-menopausal women
[26]. In our study, we found no significant effect of psyl-
lium fiber intake on serum triglycerides in both pre- and
post-menopausal women, although there was a trend
towards increased serum triglycerides.
The lack of effect of psyllium fiber intake on serum lipids
in pre-menopausal women might be due insufficient
number of subjects recruited to observe statistically signif-
icant differences. Large sample size might reveal signifi-
cant total cholesterol and/or LDL-cholesterol reduction.
Therefore, the results of this study must be used with cau-
tion. Although, we have instructed the subjects not to alter
their dietary habits during the study, it is possible that our
results may have confounded by the fiber from unin-
tended food sources. Because psyllium fiber was incorpo-
rated into cookies, consumption of psyllium enriched
cookies lead to an additional intake of ≈30 g/d fat. This
may have blunted the hypocholesterolemic effect of psyl-
lium in both pre- and post-menopausal women. Addi-
tionally, all subjects in the post-menopausal group were
Table 3: Serum lipid responses to psyllium fiber intake in pre- and post-menopausal women*
Serum lipid Pre-menopausal women (n = 8) Post-menopausal women (n = 11)
Total cholesterol
Baseline, mg/dL 243.6 ± 40.3 230.8 ± 24.4
Post-fiber, mg/dL 240.5 ± 41.2 218.7 ± 17.0#
LDL-cholesterol
Baseline, mg/dL 156.0 ± 46.0 133.4 ± 32.3
Post-fiber, mg/dL 151.0 ± 42.0 127.3 ± 14.3
HDL-cholesterol
Baseline, mg/dL 61.8 ± 12.2 65.0 ± 17.0
Post-fiber, mg/dL 61.4 ± 24.1 58.4 ± 14.8#
Triglycerides
Baseline, mg/dL 129.5 ± 52.1 139.5 ± 72.1
Post-fiber, mg/dL 139.4 ± 77.4 165.4 ± 85.2
Apolipoprotein A-1
Baseline, mg/dL 152.5 ± 30.3 150.6 ± 21.8
Post-fiber, mg/dL 154.4 ± 39.2 152.3 ± 23.8
Apolipoprotein B
Baseline, mg/dL 122.3 ± 34.7 110.6 ± 19.7
Post-fiber, mg/dL 117.1 ± 31.5 106.3 ± 16.5
* = Mean ± standard deviation. # = Significantly different from pre-menopausal women, paired t-test (p < 0.05).Page 4 of 5
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terol-lowering effect of psyllium.
In conclusion, post- and pre-menopausal women differed
with regard to lipid responses to psyllium fiber. Serum
total cholesterol was responsive to psyllium fiber in post-
menopausal women. Post-menopausal women would
likely benefit from addition of psyllium fiber to their diets
in reducing the risk of heart diseases because every 1%
reduction in serum total cholesterol concentration results
in 2% reduction in risk for heart diseases [27]. Differences
in cholesterol-lowering response to psyllium intake may
be related to the differences in hormonal status between
pre- and post-menopausal women [15,26]. Additionally,
consumption of psyllium fiber provides a low-cost
adjunct to the National Cholesterol Education Program
diets for hypercholesterolemia.
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